PARP-1 (poly(ADP-ribose) polymerase-1) plays an important role in
tumorigenesis. Since its effects on different populations are varied, this study investigated the impact of PARP-1 on primary
hepatocellular carcinoma in a Southern Chinese Zhuang population. We assessed the global PARP-1
messenger RNA expression in patients with
hepatocellular carcinoma using The
Cancer Genome Atlas dataset. Increased PARP-1 expression, related to
alpha-fetoprotein level, was observed. The area under the receiver operating characteristic curve value was 0.833. Kaplan-Meier survival curves indicated that higher PARP-1 expression was not correlated with poorer overall survival and recurrence-free survival. In a Zhuang population, PARP-1
messenger RNA and
protein levels were increased in the
hepatocellular carcinoma tissue and its adjacent liver tissues as assessed by quantitative polymerase chain reaction, immunohistochemistry, and western blotting. Higher PARP-1 level was associated with a higher
tumor stage (p < 0.05), without correlation with age, gender, smoking, drinking,
tumor size, serum
alpha-fetoprotein level,
hepatitis B virus infection,
metastasis, and invasion (p > 0.05). Further analysis suggested that H2AX, a
PARP-1 protein interaction partner, was coordinated with PARP-1 in
hepatocellular carcinoma tumorigenesis. Overall, some new characteristics of PARP-1 expression were noted in the Zhuang population. PARP-1 is a novel promising diagnostic marker for
hepatocellular carcinoma in the Southern Chinese Zhuang population.